pe
pep-04868 v1 CC-BY-SA-4.0

Blood-pressure-lowering peptide (LTDVEN)

A small peptide that blocks the body's blood-pressure-raising enzyme; studied as a potential treatment but not an approved drug.

statusbioassayed targetACE length6 aa refs3
anti-hypertensive
EARLY ENTRY This candidate is newly indexed — supporting evidence is still being added. Have a paper or data point? Contribute below.
status 2 / 5 · 0 verified on platform
prediction metrics boltz-2 1.0
ipTM0.689
pTM0.565
avg pLDDT90.9
ranking score0.865
STRUCTURE · PEP-04868 × ACE
ranking0.865
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
boltz-2 1.0 · mmCIF ↓ download
sequence6 aa
156
LTDVEN
details expand to inspect
full evidence table2 metrics
metricvaluetool
ipTM 0.6894353032112122 boltz-2
ranking score 0.8654452562332153 boltz-2
structural qualityopenfold3
metricvaluenote
gpde1.017global PDE — lower = better
disorderNaNfraction disordered
3-letter notation
Leu-Thr-Asp-Val-Glu-Asn
recipeboltz-2 1.0
parametervalue
modelboltz-2 1.0
weights
hardwarenvidia_nim_api
mlx version
python
random seed
msa strategynone
diffusion samples1
runtime
predicted bymlx@peptide
predicted at2026-04-24
citationbibtex
peptidemodel (2026). Blood-pressure-lowering peptide (LTDVEN) (pep-04868, v1). PeptideModel. https://peptidemodel.com/card/pep-04868
@peptide{pep04868,
  sequence = {LTDVEN},
  target   = {ace},
  author   = {peptidemodel},
  year     = {2026},
  status   = {bioassayed}
}
related peptides 5 by signal overlap
references 3 papers
discussion no comments
sign in to comment
peptidemodel.com CC-BY-SA-4.0 research only · not for human use